|
CDS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.895500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.195000E-01 |
| Normal-vs-Stage2 |
2.095600E-01 |
| Normal-vs-Stage3 |
5.118300E-02 |
| Normal-vs-Stage4 |
3.741600E-01 |
| Stage1-vs-Stage2 |
2.905000E-01 |
| Stage1-vs-Stage3 |
6.601800E-02 |
| Stage1-vs-Stage4 |
2.972200E-01 |
| Stage2-vs-Stage3 |
2.155000E-01 |
| Stage2-vs-Stage4 |
1.349770E-01 |
| Stage3-vs-Stage4 |
3.081700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.452420E-01 |
| Normal-vs-AfricanAmerican |
5.727800E-01 |
| Normal-vs-Asian |
4.542200E-01 |
| Caucasian-vs-AfricanAmerican |
7.148600E-01 |
| Caucasian-vs-Asian |
7.707400E-01 |
| AfricanAmerican-vs-Asian |
6.682600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.076800E-01 |
| Normal-vs-Female |
1.222440E-04 |
| Male-vs-Female |
5.169100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.110600E-01 |
| Normal-vs-Extreme_Weight |
9.816400E-01 |
| Normal-vs-Obese |
1.119840E-01 |
| Normal-vs-Extreme_Obese |
6.752000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.256600E-01 |
| Normal_Weight-vs-Obese |
6.241200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.983400E-01 |
| Extreme_Weight-vs-Obese |
1.730020E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.653000E-01 |
| Obese-vs-Extreme_Obese |
7.886400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.890400E-02 |
| Normal-vs-Age(41-60Yrs) |
5.160600E-03 |
| Normal-vs-Age(61-80Yrs) |
3.835400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.147600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.532200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.290180E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.146200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.200260E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.576600E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.352990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.278400E-01 |
| Normal-VS-Type2 PRCC |
1.351790E-01 |
| Normal-VS-KIRP CIMP |
1.070770E-01 |
| Normal-VS-Unclassified PRCC |
3.803300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.428000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.414200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.637320E-04 |
| Type2 PRCC-VS-KIRP CIMP |
6.605800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.440400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.263400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.847820E-01 |
| Normal-vs-N1 |
1.795630E-01 |
| Normal-vs-N2 |
6.860400E-01 |
| N0-vs-N1 |
7.883200E-01 |
| N0-vs-N2 |
9.349200E-01 |
| N1-vs-N2 |
9.858000E-01 |
|
|
